Mapping fragmental drug-likeness in the MoStBioDat environment: Intramolecular hydrogen bonding motifs in β-ketoenols

Combinatorial Chemistry and High Throughput Screening

Volumn 14, Issue 7, 2011, Pages 560-569

  Bak, Andrzej ^a   Magdziarz, Tomasz ^a   Kurczyk, Agata ^a   Polanski, Jaroslaw ^a  

^a UNIVERSITY OF SILESIA   (Poland)

Author keywords

ketoenols; Intramolecular hydrogen bonding; Virtual ligand screening

Indexed keywords

ALIPHATIC COMPOUND; AROMATIC COMPOUND; BETA KETOENOL; CARBONYL DERIVATIVE; DEMECLOCYCLINE; EPIRUBICIN; LIGAND; LYMECYCLINE; MELOXICAM; METACYCLINE; MINOCYCLINE; OXYTETRACYCLINE; PIROXICAM; PYRIDOXAL; ROLITETRACYCLINE; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER ANALYSIS; COMPUTER PROGRAM; DATA BASE; DRUG APPROVAL; DRUG DESIGN; DRUG STRUCTURE; FOOD AND DRUG ADMINISTRATION; GEOMETRY; HYDROGEN BOND; INTERNET; MACROMOLECULE; MOLECULAR INTERACTION; MOLECULAR MODEL; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; SCREENING; VIRTUAL REALITY;

DATABASES, FACTUAL; HIGH-THROUGHPUT SCREENING ASSAYS; HYDROGEN BONDING; KETONES; MODELS, MOLECULAR; MOLECULAR STRUCTURE; SOFTWARE; STEREOISOMERISM;

EID: 79960674168     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/138620711796367193     Document Type: Article

References (35)

1. Nunthaboot, N.; Pianwanit, S.; Parasuk, V.; Kokpol, S.; Briggs, J. Computational studies of HIV-1 integrase and its inhibitors. Curr. Comput. -Aided Drug Des., 2007, 3, 160-190.
2. Long, Y.Q.; Jiang, X.H.; Dayam, R.; Sanchez, T.; Shoemaker, R.; Sei, S.; Neamati, N. Rational design and synthesis of novel dimeric diketoacid-containing inhibitors of HIV-1 integrase: Implication for binding to two metal ions on the active site of integrase. J. Med. Chem., 2004, 47, 2561-2573. (Pubitemid 38580093)
3. Bak, A.; Polanski, J.; Kurczyk, A. The use of MoStBioDat for rapid screening of molecular diversity. Molecules, 2009, 4, 3436-3445.
4. Bak, A.; Polanski, J.; Stockner, T.; Kurczyk, A. MoStBioDat - molecular and structural bioinformatics database. Comb. Chem. High. Throughput Screen., 2010, 13, 366-374.
5. Tchertanov, L.; Mouscadet, J.F. Target recognition by catechols and beta-ketoenols: Potential contribution of hydrogen bonding and Mn/Mg chelation to HIV-1 integrase inhibition. J. Med. Chem., 2007, 50, 1133-1145. (Pubitemid 46496314)
6. Wishart, D.S.; Knox, C.; Guo, A.C.; Cheng, D.; Shrivastava, S.; Tzur, D.; Gautam, B.; Hassanali, M. DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res., 2008, 36, 901-906.
7. OEChem - Python Theory Manual, OpenEye Scientific Software Inc., 2008, Santa Fe, NM 87508.
8. O'Boyle, N.M.; Morley, C.; Hutchison, G.R. Pybel: A Python wrapper for the OpenBabel chemoinformatics toolkit. Chem. Cent. J., 2008, 9, 2-5.
9. Martelli, A. Python in a Nutshell. 2nd ed.; O'Reilly; Sebastopol, 2006
10. Berman, H.; Henrick, K.; Nakamura, H.; Markley, J.L. The worldwide Protein Data Bank (wwPDB): Ensuring a single, uniform archive of PDB data. Nucleic Acids Res., 2007, 35, 301-303.
11. Swamidass, S.J.; Baldi, P. Bounds and algorithms for fast exact searches of chemical fingerprints in linear and sublinear time. J. Chem. Inf. Model., 2007, 47, 302-317. (Pubitemid 46615935)
12. Martin, Y.C.; Kofron, J.L.; Traphagen, L.M. Do structurally similar molecules have similar biological activity? J. Med. Chem., 2002, 45, 4350-4358. (Pubitemid 35025581)
13. Podolyan, Y.; Karypis, G. Common pharmacophore identification using frequent clique detection algorithm. J. Chem. Inf. Model., 2009, 49, 13-21.
14. Schomburg, K.; Ehrlich, H.C.; Stierand, K.; Rarey, M. From structure diagrams to visual chemical patterns. J. Chem. Inf. Model., 2010, 50, 1529-1535.
15. Satoh, H.; Koshin, H.; Funatsu, K.; Nakata, T. Novel canonical coding method for representation of three-dimensional structures. J. Chem. Inf. Comput. Sci., 2000, 40, 622-630.
16. Lipinski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev., 2001, 46, 3-26. (Pubitemid 33653411)
17. Zupan, J.; Gasteiger, J. Neural Networks and drug design for Chemists. 2nd ed.; Wiley-VCH: Weinheim, 1999.
18. Bak, A.; Polanski, J.; Modeling Robust QSAR 3: SOM-4D-QSAR with iterative variable elimination IVE-PLS: Application to steroid, Azo dye and benzoic acid series. J. Chem. Inf. Model., 2007, 47, 1469-1480. (Pubitemid 47210050)
19. Bak, A.; Polanski, J. The 4D-QSAR study on anti-HIV HEPT analogues. Bioorg. Med. Chem., 2006, 14, 273-279. (Pubitemid 41635489)
20. Polanski, J.; Bak, A.; Gieleciak, R.; Magdziarz, T. Modeling robust QSAR. J. Chem. Inf. Model., 2006, 46, 2310-2308.
21. Medina-Franco, J.L.; Martinez-Mayorga, K.; Giulianotti, M.A.; Houghten, R.A.; Pinilla, C. Visualization of the chemical space in drug discovery. Curr. Comput-Aided Drug Des., 2008, 4, 322-333.
22. Polanski, J. In: Comprehensive Chemometrics, Walczak, B.; Tauler, R.; Brown, S. Ed.; Elsevier: Amsterdam, 2009, pp. 459- 506.
23. Scior, T.; Bernard, P.; Medina-Franco, J.L.; Maggiora, G.M. Large compound databases for structure-activity relationships studies in drug discovery. Mini Rev. Med. Chem., 2007, 7, 851-860. (Pubitemid 47304947)
24. Dong, X.; Gilbert, K.E.; Guha, R.; Heiland, R.; Kim, J.; Pierce, M.E.; Fox, G.C.; Wild, D.J. Web service infrastructure for chemoinformatics. J. Chem. Inf. Model., 2007, 47, 1303-1307. (Pubitemid 47210034)
25. Allen, F.H. The Cambridge Structural Database: A quarter of a million crystal structures and rising. Acta Crystallogr. B, 2002, 58, 380-388. (Pubitemid 135702674)
26. Irwin, J.; Shoichet, B., ZINC - A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 2005, 45, 177-182. (Pubitemid 40736970)
27. Brameld, K.A.; Kuhn, B.; Reuter, D.C.; Stahl, M. Small molecule conformational preferences derived from crystal structure data. A medicinal chemistry focused analysis. J. Chem. Inf. Model., 2008, 48, 1-24. (Pubitemid 351271046)
28. Sarkhel, S.; Desiraju, G.R. N-H⋯O, O-H⋯O, and C-H⋯O hydrogen bonds in protein-ligand complexes: Strong and weak interactions in molecular recognition. Proteins, 2004, 54, 247-259. (Pubitemid 38084066)
29. Corvin, C.; Kuntz, I.D In: Designing Bioactive Molecules; Martin, Y.C; Willett, P. Ed.; Am. Chem. Soc.: Washington, 1998, pp. 1-16.
30. Infantes, L.; Motherwell W.D. Hydrogen bond competition between chemical groups: New methodology and the Cambridge Structural Database. Z. Krist., 2005, 220, 333-339. (Pubitemid 40515881)
31. Pitchford, N.A.; Taylor, R. In: Designing Bioactive Molecules; Martin, Y.C; Willett, P. Ed.; Am. Chem. Soc.: Washington, 1998, pp. 19-46.
32. Bertolasi, V.; Gilli, P.; Ferretti, V.; Gilli, G. Resonance-assisted OH⋯ O hydrogen bonding: Its role in the crystalline self-recognition of beta-diketone enols and its structural and IR characterization. Chem. Eur. J., 1996, 2, 925-934.
33. Bak, A.; Magdziarz, T.; Kurczyk, A.; Polanski, J. Mapping drug architecture by MoStBioDat - Rapid screening of intramolecular hydrogen bonded motifs in catechols. Drug Dev. Res., 2011, in press.
34. Bilton, C.; Allen, F.H.; Shields, G.P.; Howard, J.A. Intramolecular hydrogen bonds: Common motifs, probabilities of formation and implications for supramolecular organization. Acta Crystallogr. B, 2000, 56, 849-856.
35. Madsen, G.K.; Iversen, B.B.; Larsen, F.K.; Kapon, M.; Reisner, G.M.; Herbstein, F.H. Topological analysis of the charge density in short intramolecular O-H⋯O hydrogen bonds. Very low temperature X-ray and neutron diffraction study of benzoylacetone. J. Am. Chem. Soc., 1998, 120, 10040-100045.